Elizabeth Dennis describes the testing process following a new lung cancer diagnosis. Initial tissue biopsy is sent for next-generation sequencing (NGS), although repeat tissue sampling or liquid biopsy from blood may be needed if the initial biopsy is insufficient for molecular profiling.
Dr. Kartik Konduri introduces the program on patient experiences with EGFR-positive NSCLC, joined by Elizabeth Dennis, an advanced practice provider at Texas Oncology at Baylor Simmons Cancer Center, and Lynn Abbott-McCloud, Executive Director of LiveLung, a nonprofit lung cancer organization.
